Table 3.
Group | Dose (mg/kg) | n | Blood glucose concentration (mM) | ||||
---|---|---|---|---|---|---|---|
0 min | 15 min | 30 min | 60 min | 120 min | |||
CON | – | 8 | 4.48 ± 0.09 | 15.77 ± 0.78 | 15.50 ± 1.01 | 12.40 ± 0.97 | 9.05 ± 0.47 |
CON + RES | 15 | 5 | 4.58 ± 0.11## | 13.2 ± 1.44## | 12.64 ± 1.45## | 11.18 ± 1.92# | 8.14 ± 0.91 |
NAFLD | – | 8 | 7.10 ± 0.16** | 25.40 ± 1.40** | 22.22 ± 1.36** | 14.14 ± 1.45 | 9.23 ± 0.75 |
NAFLD + RES | 15 | 8 | 4.56 ± 0.09## | 16.32 ± 0.56## | 13.81 ± 0.64## | 10.81 ± 0.34# | 8.31 ± 0.15 |
NAFLD + STG | 10 | 8 | 4.72 ± 0.13## | 15.46 ± 0.67## | 13.98 ± 0.82## | 11.06 ± 0.59# | 8.25 ± 0.33 |
NAFLD + RSG | 5 | 8 | 4.67 ± 0.10## | 15.56 ± 0.64## | 12.80 ± 0.48## | 10.70 ± 0.37# | 8.49 ± 0.14 |
NAFLD + FLX | 2 | 8 | 7.05 ± 0.22 | 23.64 ± 1.57 | 21.32 ± 1.22 | 12.31 ± 0.79 | 8.56 ± 0.44 |
NAFLD + DNP | 1 | 8 | 6.78 ± 0.16 | 22.32 ± 0.76# | 20.70 ± 1.21 | 13.09 ± 1.11 | 8.36 ± 0.46 |
P < 0.001 compared with the CON group;
P < 0.05 and
P < 0.001 compared with the NAFLD model group.